CML-behandeling asciminib voldoet aan verwachtingen in fase III-studie

november 2020 Farmanieuws Willem Van Altena
Hairy cell leukemia, 3D illustration. It is a hematological malignancy, chronic lymphocytic leukemia, with accumulation of abnormal B lymphocytes